• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number PLC141400
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Aneurysm (1708)
Date of Event 06/21/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Patient comorbidities: stroke, hypercholesterolemia, hypertension, diabetes mellitus, and renal insufficiency.Medications: none.The gore® excluder® aaa endoprosthesis instructions for use (ifu) states that adverse events that may occur and/or require intervention include, but are not limited to vascular trauma (e.G., ilio-femoral vessel dissection).
 
Event or Problem Description
The following information was reported to gore through the (b)(6) study for the gore® excluder® thoracoabdominal branch endoprosthesis (tambe device): on (b)(6) 2019, the patient underwent treatment of a thoracoabdominal and pararenal aortic aneurysm with gore® excluder® thoracoabdominal branch endoprosthesis and gore® tag® conformable thoracic stent graft with active control system.It was reported that during the procedure there was a left common iliac artery.A stent was placed and the study reported that the outcome was resolved.The patient tolerated the procedure.
 
Additional Manufacturer Narrative
Addition h6: code 213-the review of the manufacturing paperwork verified that this lot met all pre-release specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL SILICON VALLEY
2890 de la cruz blvd
santa clara CA 85085
Manufacturer Contact
rachael chascsa
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key10731110
Report Number3007284313-2020-01126
Device Sequence Number16909350
Product Code MIH
UDI-Device Identifier00733132618651
UDI-Public00733132618651
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
P020004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 04/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/03/2022
Device Model NumberPLC141400
Device Catalogue NumberPLC141400
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Received by Manufacturer 11/26/2019
Supplement Date Received by Manufacturer11/26/2019
11/26/2019
Initial Report FDA Received Date10/23/2020
Supplement Report FDA Received Date01/29/2021
04/22/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured09/04/2019
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age73 YR
Patient SexFemale
Patient Weight112 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-